• Reserpine (N1867): Practical Research Workflow

  2026-08-13

  Reserpine (SKU N1867) provides a characterized natural-product reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. It is intended for research use only; its insolubility in water and ethanol, potent biological activity, and limited dossier-level evidence require deliberate stock preparation, vehicle controls, and assay-specific validation.

• HotStart 2X Green qPCR Master Mix for RNA

  2026-08-12

  HotStart 2X Green qPCR Master Mix enables specific SYBR Green qPCR for gene expression, RNA-seq validation, and nucleic acid quantification. This guide connects structure-guided SARS-CoV-2 RNA discovery with practical assay design, controls, and interpretation limits.

• DDX24–NPM1 Phase Behavior in Vascular Malformations

  2026-08-12

  The reference study links the DDX24E271K mutation to altered NPM1 phase behavior, abnormal nucleolar organization, and endothelial dysfunction in vascular malformations. Its combined patient-tissue, condensate, and endothelial assays provide a mechanistic framework for connecting nucleolar material properties with disease-associated cell behavior.

• Quercetin Protects Cataract Lenses via Hippo Signaling

  2026-08-11

  A 2025 study links quercetin-mediated protection of cataract lenses to suppression of Hippo signaling, improved antioxidant status, and preservation of lens epithelial-cell viability. Its combined network-pharmacology, mouse, and cell-based design provides a useful framework for connecting pathway modulation with cataract-associated oxidative injury, while also highlighting important limits in causal and translational interpretation.

• G418 Sulfate: Selection and Assay Workflows

  2026-08-11

  Geneticin enables stringent selection of engineered cells while supporting carefully controlled antiviral experiments. This workflow-focused guide connects kill-curve design, stable cell-line development, Dengue virus assays, and VHL-focused cancer biology without confusing selection effects with treatment responses.

• Lypressin Acetate: An Assay-First Guide

  2026-08-10

  Lypressin acetate is a multidimensional vasopressin receptor agonist for antidiuretic, vasoconstriction, and translational research. This assay-first guide explains how sequence, receptor coupling, activity benchmarks, stability, and emerging antiviral evidence should shape experimental decisions.

• EZ Cap™ Firefly Luciferase mRNA for LNP Assays

  2026-08-08

  EZ Cap™ Firefly Luciferase mRNA enables sensitive, mechanistically interpretable reporter assays. This article shows how Cap1 architecture, transcript handling, LNP size, cellular ATP, and assay timing collectively determine the meaning of a bioluminescence signal.

• FAK Inhibitor 14 in EMT Research

  2026-08-07

  FAK Inhibitor 14 provides a practical pharmacological test of FAK-dependent adhesion, migration, and EMT signaling in cholesterol-conditioned ovarian cancer models. This workflow combines pathway readouts with functional assays to distinguish direct signaling effects from changes in proliferation or cell viability.

• Amyloid Beta-peptide (25-35): Applied Neurotoxicity Modeling

  2026-08-07

  Amyloid Beta-peptide (25-35) (human) empowers robust, reproducible modeling of Alzheimer's disease neurotoxicity and microglial polarization. This article delivers actionable protocols, troubleshooting strategies, and insights from the latest mechanistic research, driving innovation in neurodegenerative disease studies.

• UTP Solution: Advancing In Vitro Transcription and RNA Workf

  2026-08-06

  UTP Solution (100 mM) empowers researchers with ultrapure, DNase/RNase-free uridine-5'-triphosphate trisodium salt for high-fidelity RNA synthesis and metabolic assays. Discover how this reagent enhances experimental reliability, streamlines sensitive protocols, and addresses common troubleshooting challenges in cutting-edge molecular biology.

• Mechanistic Cell Fate Analysis: Strategic AO/PI Staining for

  2026-08-06

  Explore the mechanistic power and translational impact of the AO/PI Double Staining Kit in advanced cell viability and apoptosis detection. This article bridges recent glioma organoid modeling breakthroughs with practical, protocol-driven guidance, offering strategic insights for researchers aiming to elevate experimental rigor and translational relevance in oncology and drug screening workflows.

• Histone H4K12 Lactylation Drives TNBC via SLFN5 Suppression

  2026-08-05

  This study reveals that histone H4K12 lactylation, induced by elevated lactate in triple-negative breast cancer (TNBC), promotes tumor progression by downregulating the tumor suppressor SLFN5. It establishes a mechanistic link between tumor metabolism and epigenetic reprogramming, and demonstrates that inhibiting lactate production—using metabolic inhibitors such as sodium oxamate—can reverse this malignancy-driving axis.

• Pharmacological Induction of Embryonic Dormancy via mTOR Inh

  2026-08-05

  This article summarizes a protocol for inducing a reversible, dormancy-like state in mammalian embryonic cells and pluripotent stem cells using pharmacological mTOR inhibition. The approach enables noninvasive, scalable studies of diapause and cellular dormancy, with implications for reproductive biology and developmental research.

• β-Elemene Suppresses Adipogenesis via AMPK Activation in 3T3

  2026-08-04

  This study demonstrates that β-Elemene inhibits adipogenesis in 3T3-L1 preadipocytes by activating the AMPK pathway, reversing insulin resistance-induced lipid accumulation. These findings highlight β-Elemene's potential as a molecular tool for probing obesity mechanisms and developing metabolic research models.

• WY-14643 (Pirinixic Acid): Applied Workflows in Metabolic Re

  2026-08-04

  WY-14643 (Pirinixic Acid) stands out as a selective PPARα agonist, streamlining advanced metabolic and inflammation studies with robust reproducibility. This guide translates cutting-edge research into practical protocols, troubleshooting strategies, and assay enhancements for metabolic disorder and tumor microenvironment research.

7710 records 4/514 page Previous Next 12345 下5页 Last page